Evaluating the Safety and Benefits of Reducing or Stopping csDMARD Therapy in Patients With Rheumatoid or Psoriatic Arthritis in Sustained Remission
This Cochrane review protocol outlines a plan to evaluate whether reducing or discontinuing conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) is ...
Read moreDetails